Skip to main content
. Author manuscript; available in PMC: 2015 Aug 20.
Published in final edited form as: Transfusion. 2013 Jul 7;53(10 0 2):2505–2511. doi: 10.1111/trf.12326

Figure 3. Suspected, but unconfirmed anti-HEV IgG seroconversion in two blood recipients.

Figure 3

Recipient 1 received one HEV RNA+ and one high titer anti-HEV IgG+ blood unit 4 days before the sample collected at 36 weeks after the index study transfusion. The patient died shortly after receiving the HEV RNA+ unit and thus the consequences of that transfusion could not be assessed.

Recipient 2 could be interpreted as having a very early seroconversion post-transfusion, but more likely was infected prior to the index transfusion based on the timing and on the pre-transfusion sample having a relatively high, albeit below cut-off.